跳至主要内容
临床试验/NCT03775733
NCT03775733Unknown不适用

A 12 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate The Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Hyperglycemia

Chonbuk National University Hospital2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年9月7日最近更新:
适应症

试验速览

阶段
不适用
入组人数
80
试验地点
2
主要终点
Changes of blood glucose

研究概览

简要总结

This study was conducted to investigate the effects of daily supplementation of hydrolysed red ginseng extract on improvement of Hyperglycemia.

详细描述

This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Twenty subjects were randomly divided into Hydrolysed Red Ginseng extract or a placebo group. Fasting and postprandial glucose profiles during oral glucose tolerance test (OGTT) were assessed before and after the intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 19-80 years with fasting glucose 100-140 mg/dL

排除标准

  • Weight less than 48 kg or weight decreased by more than 10% within past 3 months
  • Have clinically significant acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, hepatic biliary system, kidney and Urinary system, neuropsychiatry, musculoskeletal, inflammatory and hematologic malignancies, gastrointestinal disorders, etc.
  • Hypoglycemic agent, Obesity medicine, Lipid lowering agent within past 3 months
  • Blood sugar improvement or healthy functional food within past 1 month
  • Under antipsychotic medication therapy within past 2 months
  • History of alcohol or substance abuse
  • Participation in any other clinical trials within past 2 months
  • Laboratory test by show the following results
  • aspartate aminotransferase, alanine aminotransferase > Reference range 3 times upper limit
  • Serum Creatinine > 2.0 mg/dl
  • Pregnancy or breast feeding
  • If a woman of childbearing doesn't accept the implementation of appropriate contraception
  • Principal Investigator judged inappropriate for participation in study because of Laboratory test result, etc.

结局指标

主要结局

Changes of blood glucose

时间窗: 12 weeks

Changes of fasting and postprandial glucose during OGTT were assessed before and after the intervention.

次要结局

  • Changes of blood insulin(12 weeks)
  • Changes of area under the curve of Glucose and Insulin(12 weeks)
  • Changes of Homeostatic model assessment-insulin resistance(12 weeks)
  • Changes of Homeostatic model assessment-beta-cell(12 weeks)
  • Changes of HbA1c(12 weeks)
  • Changes of C-peptide(12 weeks)
  • Changes of lipid profile(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Soo-Wan Chae

Principal Investigator, Clinical Trial Center for Functional Foods

Chonbuk National University Hospital

研究点 (2)

Loading locations...

相似试验

Efficacy and Safety of Hydrolysed Red Ginseng... | 临床试验